Sinufrin

Description

SinuFrin is a sterile, isotonic saline solution formulated with sodium chloride at a concentration of 0.9% w/v. The solution is characterized by its clear and colorless appearance. It is packaged in a 30 mL bottle and contains inactive ingredients, which include sodium bicarbonate and purified water.

Uses and Indications

This drug is indicated for the temporary relief of nasal congestion associated with the common cold, sinusitis, hay fever, and upper respiratory allergies.

There are no teratogenic or nonteratogenic effects reported for this medication.

Dosage and Administration

For adults and children aged 6 to 12 years, the recommended dosage is 2 sprays in each nostril, administered not more frequently than every 10 to 12 hours. It is important to ensure that the total number of doses does not exceed 2 in any 24-hour period.

For children under 6 years of age, it is advised to consult a healthcare professional before administration.

Contraindications

This product is contraindicated in patients with heart disease, high blood pressure, thyroid disease, or diabetes unless directed by a healthcare professional. Additionally, adult males with prostate disease should not use this product.

Prolonged use may lead to a recurrence or worsening of nasal congestion. It is also advised not to use this product for more than three consecutive days and to use it only as directed.

Warnings and Precautions

The recommended dosage should not be exceeded, as this product may induce temporary discomfort, including burning, stinging, sneezing, or an increase in nasal discharge. It is important to note that sharing this container with others may facilitate the spread of infection.

This product must be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

The product is not intended for use beyond three consecutive days. It should be utilized strictly as directed, as frequent or prolonged use may lead to a recurrence or worsening of nasal congestion. If symptoms persist after three consecutive days of use, consultation with a healthcare professional is recommended. Additionally, this product is contraindicated in individuals with heart disease, high blood pressure, thyroid disease, or diabetes unless specifically directed by a physician. Adult males with prostate disease should also refrain from using this product.

If nasal congestion symptoms persist after three consecutive days of use, the patient should discontinue use and consult a healthcare provider for further evaluation and management.

Side Effects

Patients using this product may experience temporary discomfort, which can include burning, stinging, sneezing, or an increase in nasal discharge. It is important to note that the use of this container by more than one person may lead to the spread of infection.

In clinical practice, it is advised that patients stop using this product after 3 consecutive days. If symptoms of nasal congestion persist beyond this duration, patients should consult their doctor. Prolonged or frequent use of the product may result in a recurrence or worsening of nasal congestion.

Additionally, patients with pre-existing conditions such as heart disease, high blood pressure, thyroid disease, or diabetes should avoid using this product unless directed by a healthcare professional.

Drug Interactions

The use of this product is contraindicated in patients with a history of heart disease, high blood pressure, thyroid disease, or diabetes unless specifically directed by a healthcare professional. Additionally, adult males with prostate disease should refrain from using this product.

No specific interactions with laboratory tests have been identified in the available data.

Packaging & NDC

Below are the non-prescription pack sizes of Sinufrin (oxymetazoline hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 to 12 years may receive 2 sprays in each nostril, administered no more frequently than every 10 to 12 hours, with a maximum of 2 doses in a 24-hour period. For children under 6 years of age, consultation with a healthcare provider is advised prior to use.

It is essential to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical intervention is recommended. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Additionally, it is crucial to consult local poison control centers or toxicology experts for guidance on specific management protocols and antidotes, if applicable. Continuous monitoring and reassessment of the patient's condition are vital to ensure optimal outcomes.

In summary, while specific overdosage information is not available, healthcare professionals should remain vigilant and prepared to implement standard overdose management strategies.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a healthcare professional prior to use. No non-teratogenic effects have been provided in the available data. Additionally, there is no information regarding nonclinical toxicology or animal pharmacology and toxicology in the insert.

Postmarketing Experience

Postmarketing experience has revealed reports of adverse reactions, including burning, stinging, sneezing, and an increase in nasal discharge. Additionally, frequent or prolonged use may lead to a recurrence or worsening of nasal congestion. There are also reports indicating that the use of this product by more than one person may facilitate the spread of infection.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed that this product should not be used for more than 3 consecutive days and must be used only as directed. Emphasize that frequent or prolonged use may lead to a recurrence or worsening of nasal congestion. If symptoms persist after 3 consecutive days of use, patients should consult a doctor.

It is important to caution patients against using this product if they have heart disease, high blood pressure, thyroid disease, or diabetes unless directed by a healthcare professional. Additionally, adult males with prostate disease should be advised not to use this product.

Patients should be instructed to maintain an upright head position during use and to avoid tilting their head backward while spraying. Remind them to wipe the nozzle clean after each use to ensure proper hygiene and functionality.

Storage and Handling

The product is supplied in packaging that includes specific NDC numbers, which should be referenced for identification. It is essential to store the product at temperatures ranging from 20 to 40 °C (68 to 104 °F) to maintain its integrity and efficacy.

Healthcare professionals are advised to retain the carton for future reference regarding the full labeling information, ensuring that all necessary details are readily accessible for proper handling and administration.

Additional Clinical Information

The route of administration for the medication is nasal. Clinicians should advise patients who are pregnant or breastfeeding to consult a healthcare professional prior to use. No further information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Sinufrin, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)